Compare Smith & Nephew plc (SNN) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Sprott Uranium Miners ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Sprott Uranium Miners ETF trades at $50.32. The key difference: Smith & Nephew plc pays a 2.57% dividend while Sprott Uranium Miners ETF pays none. Which is the better fit depends on your goals.
| SNN | URNM | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $38.70 | $83.99 |
52-Week Low | $28.73 | $44.14 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
URNM trades at $48.25 with minimal daily movement (+0.06%). The ETF shows bearish technical signals with moving averages indicating selling pressure, though RSI suggests potential oversold conditions. Recent news highlights uranium's role in AI power demand, with nuclear energy positioned as a solution to data center electricity needs. The fund has gained significant attention for its pure-play uranium miner exposure versus broader nuclear ETFs.
The uranium sector faces a favorable long-term outlook with projected nuclear demand tripling by 2050, though current technical weakness and concentration risks in mining companies present near-term challenges. URNM offers leveraged exposure to uranium price movements but remains vulnerable to sector volatility and supply chain constraints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
